Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829575) titled 'Amygdala-Targeted Transcranial Temporal Interference Stimulation for Major Depressive Disorder: A Randomized Sham-Controlled Trial of Clinical Efficacy and Neurobiological Mechanisms' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Condition:
Major Depressive Disorder (MDD
Intervention:
Device: Transcranial Temporal Interference Stimulation
Recruitme...